NCT05737706
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05737706
Title Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 311 Phoenix Arizona 85054 United States Details
Local Institution - 309 New Haven Connecticut 06520 8028 United States Details
Local Institution - 301 Lady Lake Florida 32159 8987 United States Details
Local Institution - 306 Baltimore Maryland 21231 United States Details
Local Institution - 308 Boston Massachusetts 02114 3117 United States Details
Local Institution - 310 Boston Massachusetts 02215 United States Details
Local Institution - 314 Grand Rapids Michigan 49546 United States Details
Local Institution - 312 New York New York 10065 6800 United States Details
Local Institution - 303 Nashville Tennessee 37203 United States Details
Local Institution - 302 Houston Texas 77030 United States Details
Local Institution - 304 San Antonio Texas 78229 3307 United States Details
Local Institution - 313 San Antonio Texas 78229 United States Details
Local Institution - 305 Fairfax Virginia 22031 United States Details
Local Institution - 307 Seattle Washington 98109 1023 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field